Anúncio
Anúncio
NEUP
Neuphoria Therapeutics Inc. Common Stock
4.17
USDPatrocinado
+0.10
+2.58%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
4.24
+0.07
+1.65%
Relatórios de Lucros NEUP
Rácio de surpresa positiva
NEUP separação 0 de 2 últimas estimativas.
%
Próximo Relatório
Data do Próximo Relatório
12 de fev. de 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$1.49
Mudanças implicadas de Q1 26 (Revenue/ EPS)
--
/-66.21%
Mudanças implicadas de Q2 25 (Revenue/ EPS)
--
/--
Neuphoria Therapeutics Inc. Common Stock earnings per share and revenue
On 14 de nov. de 2025, NEUP reported earnings of -4.41 USD per share (EPS) for Q1 26, missing the estimate of -1.35 USD, resulting in a -225.89% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.84% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analistas forecast an EPS of -1.49 USD, with revenue projected to reach -- USD, implying an diminuir of -66.21% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Neuphoria Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Neuphoria Therapeutics Inc. Common Stock reported EPS of -$4.41, missing estimates by -225.89%, and revenue of $0.00, 0% as expectations.
How did the market react to Neuphoria Therapeutics Inc. Common Stock's Q1 2026 earnings?
The stock price moved up 0.84%, changed from $4.75 before the earnings release to $4.79 the day after.
When is Neuphoria Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for 12 de fev. de 2026.
What are the forecasts for Neuphoria Therapeutics Inc. Common Stock's next earnings report?
Based on 5
analistas, Neuphoria Therapeutics Inc. Common Stock is expected to report EPS of -$1.49 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio